CREATE Medicines to Host Investor and Partnering Meetings at the 2026 Jefferies Global Healthcare Conference in London

The Quick Take
Discussions will highlight progress from CREATE's four clinical-stage in vivo CAR programs across autoimmune disease and oncology CAMBRIDGE, Mass., Nov. 6, 2026 /PRNewswire/ -- CREATE Medicines, Inc. ("CREATE"), a clinical-stage biotechnology company pioneering in vivo multi-immune...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Local
Spoločne pre mestskú budúcnosť poháňanú AI: Dahua Technology predstavuje na konferencii SCEWC 2026 praktické riešenia AIoT
BARCELONA, Španielsko, 6. novembra 2026 /PRNewswire/ – Spoločnosť Dahua Technology, popredný svetový poskytovateľ riešení a služieb AIoT so zameraním na video,…
Local
Treasury, IRS finalize new Opportunity Zone designations
The Opportunity Zone program has attracted more than $110 billion in private investment since 2017, mostly from residential developers
Business
Segway Powersports zacieśnia współpracę z europejskimi dealerami podczas targów EICMA 2026
MEDIOLAN, 6 listopada 2026 r. /PRNewswire/ -- Segway Powersports, linia wysokiej klasy pojazdów sportowo-rekreacyjnych marki Segway, wyróżniających się…
Local
Report: Southern Nevada home sales slip again as mortgage rates rise - Las Vegas Sun
Report: Southern Nevada home sales slip again as mortgage rates rise Las Vegas Sun
